stelfonta - EBC46 Research Hub

Regulatory

EBC-46 Regulatory Landscape 2026: Stelfonta Approvals and DSHEA Framework

How tigilanol tiglate is regulated across jurisdictions — from FDA veterinary approval of Stelfonta to DSHEA's established framework for botanical dietary supplements.

stelfonta

Stelfonta: How EBC-46 Conquered Canine Cancer and Changed the Course of Oncology Research

How EBC-46 became Stelfonta® — the first FDA and EMA approved intratumoral cancer treatment — through rigorous canine clinical trials, and what this milestone means for the ongoing Phase I/II human cancer trials.